Pages that link to "Q37387870"
Jump to navigation
Jump to search
The following pages link to Garnet L Anderson (Q37387870):
Displaying 50 items.
- Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial (Q28194938) (← links)
- Long-term exposure to air pollution and incidence of cardiovascular events in women (Q28286071) (← links)
- Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial (Q28296300) (← links)
- Calcium plus vitamin D supplementation and the risk of colorectal cancer (Q28297713) (← links)
- Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts (Q28308282) (← links)
- Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET). (Q30418252) (← links)
- Efficacy of yoga for vasomotor symptoms: a randomized controlled trial (Q30560613) (← links)
- Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit (Q30986838) (← links)
- Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease (Q33234184) (← links)
- Effects of blood collection conditions on ovarian cancer serum markers (Q33308744) (← links)
- Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial (Q33567637) (← links)
- Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial (Q33717993) (← links)
- Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. (Q33739861) (← links)
- Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative (Q33783215) (← links)
- Genome-wide association study identifies multiple risk loci for renal cell carcinoma (Q33804470) (← links)
- Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial (Q33810759) (← links)
- The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women (Q33838504) (← links)
- Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy (Q33898159) (← links)
- Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium (Q34094983) (← links)
- Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial (Q34145853) (← links)
- Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study (Q34147730) (← links)
- Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage (Q34213725) (← links)
- Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial (Q34266113) (← links)
- The Women's Health Initiative recruitment methods and results (Q34272010) (← links)
- Menopausal hormone therapy and cancer: changing clinical observations of target site specificity (Q34315478) (← links)
- Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. (Q34319242) (← links)
- Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study (Q34336219) (← links)
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial (Q34370566) (← links)
- Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial (Q34492832) (← links)
- Calcium plus vitamin D supplementation and the risk of fractures (Q34495055) (← links)
- Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. (Q34512916) (← links)
- Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. (Q34543818) (← links)
- Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin (Q34758422) (← links)
- The women's health initiative: lessons learned (Q34762689) (← links)
- Breast cancer after use of estrogen plus progestin in postmenopausal women (Q34938322) (← links)
- The case for early detection (Q35097361) (← links)
- Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study (Q35188724) (← links)
- Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagus (Q35778939) (← links)
- Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms (Q35919965) (← links)
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial (Q36143058) (← links)
- Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative (Q36191949) (← links)
- Use of alternative time scales in Cox proportional hazard models: implications for time-varying environmental exposures (Q36310007) (← links)
- Identifying post-menopausal women at elevated risk for epithelial ovarian cancer (Q36331643) (← links)
- Statistical issues arising in the Women's Health Initiative (Q36364054) (← links)
- Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer (Q36384972) (← links)
- Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative (Q36553497) (← links)
- Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) (Q36819921) (← links)
- Circulating Metabolites and Survival Among Patients With Pancreatic Cancer (Q36848069) (← links)
- New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk (Q36896822) (← links)
- Breast tenderness after initiation of conjugated equine estrogens and mammographic density change (Q36937185) (← links)